The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Robert F. Kennedy Jr. told the Senate Finance Committee that he is not anti-vaccine during his confirmation hearing for ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Michael Batnick said the outperformance of consumer discretionary stocks relative to consumer staples is "the most bullish ...

"Investors are questioning the long-term impact of revolutionary weight loss drugs like Ozempic on food and beverage ... and this is the chart that is giving me confidence," Batnick said in ...

A new study documents the dramatic change in America's material diet from 1900 to 2020—ongoing shifts in US commodity ...

As I reported in yesterday’s Mail, another bespoke medical service is couriering Ozempic and other weight ... app for celebrities – were ‘off the charts’. She ended up having a drink ...

with such brands as Ozempic and Jardiance spending north of $10 million a month on national TV ads alone and Skyrizi topping the charts with more than $30 million a month in TV ad spend.